BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 10632475)

  • 1. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of adult patients with sepsis-induced coagulopathy and purpura fulminans using a plasma-derived protein C concentrate (Ceprotin).
    Schellongowski P; Bauer E; Holzinger U; Staudinger T; Frass M; Laczika K; Locker GJ; Quehenberger P; Rabitsch W; Schenk P; Knöbl P
    Vox Sang; 2006 May; 90(4):294-301. PubMed ID: 16635072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement treatment with protein C in an 18-year-old man with meningococcal sepsis and purpura fulminans.
    Vaccarella G; Pelella R
    Minerva Anestesiol; 2003 Sep; 69(9):691-3, 693-5. PubMed ID: 14564239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].
    Llinares Tello F; Hernández Prats C; Burgos San José A; Bosacoma Ros N; Alcalá Minagorre P; López Rodríguez F; Reig Sáenz R; Marco Vera P; Ordovás Baines JP
    Farm Hosp; 2004; 28(2):130-6. PubMed ID: 15101805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia.
    White B; Livingstone W; Murphy C; Hodgson A; Rafferty M; Smith OP
    Blood; 2000 Dec; 96(12):3719-24. PubMed ID: 11090052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
    Salinas U; Unzueta J; Vidarte MA; Rodrigo MP; Gómez JJ; Aguilera L
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency.
    Dreyfus M; Masterson M; David M; Rivard GE; Müller FM; Kreuz W; Beeg T; Minford A; Allgrove J; Cohen JD
    Semin Thromb Hemost; 1995; 21(4):371-81. PubMed ID: 8747700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis].
    Pettenazzo A; Malusa T
    Minerva Anestesiol; 2004 May; 70(5):357-63. PubMed ID: 15181416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.
    Fourrier F; Leclerc F; Aidan K; Sadik A; Jourdain M; Tournoys A; Noizet O
    Intensive Care Med; 2003 Jul; 29(7):1081-7. PubMed ID: 12761614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of purpura fulminans in meningococcemia with protein C concentrate.
    Rivard GE; David M; Farrell C; Schwarz HP
    J Pediatr; 1995 Apr; 126(4):646-52. PubMed ID: 7699550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of a patient with purpura fulminans syndrome due to protein C deficiency.
    Kumagai K; Nishiwaki K; Sato K; Kitamura H; Yano K; Komatsu T; Shimada Y
    Can J Anaesth; 2001 Dec; 48(11):1070-4. PubMed ID: 11744581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein C deficiency.
    Goldenberg NA; Manco-Johnson MJ
    Haemophilia; 2008 Nov; 14(6):1214-21. PubMed ID: 19141162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C substitution in sepsis-associated purpura fulminans.
    Rintala E; Kauppila M; Seppälä OP; Voipio-Pulkki LM; Pettilä V; Rasi V; Kotilainen P
    Crit Care Med; 2000 Jul; 28(7):2373-8. PubMed ID: 10921567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulopathy of sepsis.
    Dempfle CE
    Thromb Haemost; 2004 Feb; 91(2):213-24. PubMed ID: 14961146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate.
    Gerson WT; Dickerman JD; Bovill EG; Golden E
    Pediatrics; 1993 Feb; 91(2):418-22. PubMed ID: 8424021
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
    Fijnvandraat K; Derkx B; Peters M; Bijlmer R; Sturk A; Prins MH; van Deventer SJ; ten Cate JW
    Thromb Haemost; 1995 Jan; 73(1):15-20. PubMed ID: 7740486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
    Mertens R; Peschgens T; Granzen B; Heimann G
    Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meningococcal purpura fulminans in children].
    Leclerc F; Binoche A; Dubos F
    Rev Prat; 2004 May; 54(9):957-62. PubMed ID: 15296272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.